• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根除幽门螺杆菌对复发性腹痛儿童的症状性反应:双盲随机安慰剂对照试验。

Symptomatic response to Helicobacter pylori eradication in children with recurrent abdominal pain: double blind randomized placebo-controlled trial.

作者信息

Ashorn Merja, Rägö Tiina, Kokkonen Jorma, Ruuska Tarja, Rautelin Hilpi, Karikoski Riitta

机构信息

Department of Paediatrics, Tampere University Hospital, Tampere, Finland.

出版信息

J Clin Gastroenterol. 2004 Sep;38(8):646-50. doi: 10.1097/01.mcg.0000135366.58536.b3.

DOI:10.1097/01.mcg.0000135366.58536.b3
PMID:15319645
Abstract

BACKGROUND

Controlled trials considering the effect of Helicobacter pylori (H. pylori) eradication on gastrointestinal symptoms in children are scant. We aimed to study the connection between recurrent abdominal pain and dyspepsia and H. pylori infection in children.

STUDY

This was a double blind randomised controlled trial. Twenty children with recurrent abdominal pain (RAP) being H. pylori positive as measured with the C urea breath test (UBT) were randomized either to receive omeprazole, amoxycillin and clarithromycin (n = 10), or omeprazole and 2 placebos (n = 10) for 1 week after gastroscopy. Symptoms were registered prior to the treatment and at follow up visits 2, 6, 24, and 52 weeks after stopping the treatment. Control UBT was performed on all patients 6 weeks post-treatment and again at the 52 week follow-up visit, when also re-endoscopy with biopsies was done to all participants.

RESULTS

All infected children had histologic gastritis. Bacterial eradication was achieved in 8/10 in the triple treatment group and in none in the placebo group. There was no change in symptom index in either group at 2 weeks post treatment. At 52 weeks a similar reduction in symptom index was observed in both groups irrespective of the healing of gastritis, which was more commonly achieved along the eradication.

CONCLUSIONS

Bacterial eradication and healing of gastric inflammation does not lead to symptomatic relief of chronic abdominal pain in children.

摘要

背景

关于幽门螺杆菌(H. pylori)根除对儿童胃肠道症状影响的对照试验很少。我们旨在研究儿童反复腹痛、消化不良与H. pylori感染之间的联系。

研究

这是一项双盲随机对照试验。20名经C尿素呼气试验(UBT)检测为H. pylori阳性的反复腹痛(RAP)儿童,在胃镜检查后随机分为两组,一组接受奥美拉唑、阿莫西林和克拉霉素治疗(n = 10),另一组接受奥美拉唑和两种安慰剂治疗(n = 10),疗程均为1周。在治疗前以及停止治疗后2周、6周、24周和52周的随访中记录症状。所有患者在治疗后6周进行对照UBT检测,在52周随访时再次进行检测,此时所有参与者均再次接受内镜检查并取活检。

结果

所有感染儿童均有组织学胃炎。三联治疗组10例中有8例实现细菌根除,安慰剂组无1例根除。治疗后2周两组症状指数均无变化。在52周时,两组症状指数均有类似程度下降,无论胃炎是否愈合,胃炎愈合在根除治疗中更常见。

结论

根除细菌和治愈胃炎症并不能缓解儿童慢性腹痛的症状。

相似文献

1
Symptomatic response to Helicobacter pylori eradication in children with recurrent abdominal pain: double blind randomized placebo-controlled trial.根除幽门螺杆菌对复发性腹痛儿童的症状性反应:双盲随机安慰剂对照试验。
J Clin Gastroenterol. 2004 Sep;38(8):646-50. doi: 10.1097/01.mcg.0000135366.58536.b3.
2
[new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].[采用甲硝唑的新型一周三联疗法根除幽门螺杆菌:以克拉霉素或阿莫西林作为第二种抗生素]
Med Clin (Barc). 1998 Jan 17;110(1):1-5.
3
Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.连续两种双重疗法(奥美拉唑与阿莫西林或奥美拉唑与克拉霉素)使幽门螺杆菌感染根除率显著提高。一项针对450名西班牙患者的随机研究。
J Gastroenterol. 1996 Nov;31 Suppl 9:48-52.
4
Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.根除幽门螺杆菌治疗功能性消化不良:一项为期12个月随访的随机双盲安慰剂对照试验。最佳方案治愈幽门螺杆菌所致消化不良(ORCHID)研究组。
BMJ. 1999 Mar 27;318(7187):833-7. doi: 10.1136/bmj.318.7187.833.
5
Helicobacter pylori infection in recurrent abdominal pain.复发性腹痛中的幽门螺杆菌感染
J Pediatr Gastroenterol Nutr. 2000 Oct;31(4):424-7. doi: 10.1097/00005176-200010000-00017.
6
Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.奥美拉唑、阿莫西林和克拉霉素三联疗法治疗幽门螺杆菌感染消化性溃疡患者1周与2周的比较:一项随机对照试验的结果
J Gastroenterol. 1999;34 Suppl 11:76-9.
7
Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.幽门螺杆菌感染治疗对非溃疡性消化不良患者无效。奥美拉唑联合克拉霉素和阿莫西林治疗一年后效果(OCAY)研究组。
N Engl J Med. 1998 Dec 24;339(26):1875-81. doi: 10.1056/NEJM199812243392602.
8
Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagotomized patients with dyspeptic complaints. A randomized, double-blind, placebo-controlled, clinical study without pretreatment diagnostic upper endoscopy.兰索拉唑、阿莫西林和克拉霉素三联疗法用于迷走神经切断术后有消化不良症状的患者。一项随机、双盲、安慰剂对照且无预处理诊断性上消化道内镜检查的临床研究。
Scand J Gastroenterol. 1998 Mar;33(3):231-5. doi: 10.1080/00365529850170775.
9
Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.幽门螺杆菌根除治疗对非溃疡性消化不良患者并无益处。
Am J Gastroenterol. 2001 Aug;96(8):2329-36. doi: 10.1111/j.1572-0241.2001.04037.x.
10
Seven-day triple therapy with omeprazole, amoxycillin and clarithromycin for Helicobacter pylori infection in haemodialysis patients.奥美拉唑、阿莫西林和克拉霉素七日三联疗法治疗血液透析患者幽门螺杆菌感染
Scand J Gastroenterol. 2002 Nov;37(11):1265-8. doi: 10.1080/003655202761020524.

引用本文的文献

1
Antimicrobial Resistance and the Role of Next-Generation Sequencing.抗菌药物耐药性与新一代测序技术的作用
Gastroenterol Hepatol (N Y). 2024 Aug;20(8):469-476.
2
A randomised controlled clinical study of standard triple therapy, bismuth-based quadruple therapy and sequential therapy for Helicobacter pylori infection in children.儿童幽门螺杆菌感染的标准三联疗法、铋四联疗法和序贯疗法的随机对照临床研究。
BMC Pediatr. 2024 Aug 23;24(1):543. doi: 10.1186/s12887-024-05020-6.
3
Infections in Children.儿童感染
Antibiotics (Basel). 2023 Sep 12;12(9):1440. doi: 10.3390/antibiotics12091440.
4
The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.《儿童幽门螺杆菌感染管理的 JSPGHAN 指南更新版》。
Pediatr Int. 2020 Dec;62(12):1315-1331. doi: 10.1111/ped.14388.
5
Helicobacter pylori Infection in Pediatric Patients: Update on Diagnosis and Eradication Strategies.儿童患者的幽门螺杆菌感染:诊断和根除策略的最新进展。
Paediatr Drugs. 2018 Aug;20(4):337-351. doi: 10.1007/s40272-018-0296-y.
6
Diagnostic yield of esophagogastroduodenoscopy in children with chronic abdominal pain.食管胃十二指肠镜检查对慢性腹痛儿童的诊断价值
Arch Med Sci. 2018 Jan;14(1):74-80. doi: 10.5114/aoms.2017.67675. Epub 2017 Jul 31.
7
Prevalence of Helicobacter Pylori among Sudanese children admitted to a specialized children hospital.一家专业儿童医院收治的苏丹儿童中幽门螺杆菌的感染率
Sudan J Paediatr. 2017;17(1):14-18.
8
Symptomatic infantile Helicobacter pylori gastritis infection in indigenous African infants: a case series.非洲本土婴儿的症状性幽门螺杆菌胃炎感染:病例系列
Pan Afr Med J. 2014 Sep 25;19:83. doi: 10.11604/pamj.2014.19.83.4801. eCollection 2014.
9
What do we know about benefits of H. pylori treatment in childhood?我们对儿童时期幽门螺杆菌治疗的益处了解多少?
Gut Microbes. 2013 Nov-Dec;4(6):549-67. doi: 10.4161/gmic.27000. Epub 2013 Nov 6.
10
A localized case-control study of extra-gastric manifestations of Helicobacter pylori infection in children.儿童幽门螺杆菌感染的胃外表现的局部病例对照研究。
Indian J Pediatr. 2011 Apr;78(4):418-22. doi: 10.1007/s12098-010-0308-6. Epub 2010 Dec 17.